Hyku Biosciences

Drug Discovery · Burlington, MA · Founded 2021 · Privately Held (backing)

Developer of small molecule therapeutics with novel mechanisms of action intended to inhibit proteins that drive disease progression potently. Hyku Biosciences is based in Burlington, MA and was founded in 2021. It was valued at $85 million at its seed round in Nov 2024, the last priced event on record. It has raised $70.6 million across 2 recorded rounds; the latest was a $6.6 million debt round in Dec 2025.

PMV mark · valuation
$85.0M
Oct 2026
Priced at
its seed round
Nov 2024
Total raised
$70.6M
Last round
Debt
Dec 2025
How much has Hyku Biosciences raised?
$70.6Macross 2 recorded rounds · Nov 2024 – Dec 2025

Most recently, Hyku Biosciences raised $6.6M in its Debt (Dec 2025).

Free account
More of Hyku Biosciences with a free account
  • ·Watch Hyku Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Hyku Biosciences round by round

2 rounds
Dec 2025Debt$6.6MSEC filing▮
8 investors participated
Nov 2024Seed Round$64.0M▮
+ 1 more investors · free account

How much has Hyku Biosciences raised?

Hyku Biosciences has raised $70.6 million across 2 recorded rounds since 2024. The largest was a $6.6 million debt round in Dec 2025.

Hyku Biosciences investors

7 investors are on record for Hyku Biosciences, including RA Capital Management, KB Investment, Novartis Venture Fund and Chugai Venture Fund. The debt round in Dec 2025 drew 8 investors.

For fundraisers
Raising for a company like Hyku Biosciences?

7 investors have backed Hyku Biosciences — start your target list with the firms already writing checks in drug discovery.

See all 7 investors →

Frequently asked about Hyku Biosciences

How much has Hyku Biosciences raised?
Hyku Biosciences has raised $70.6M in total across 2 recorded funding rounds.
When was Hyku Biosciences's last funding round?
Hyku Biosciences's most recent recorded round was Debt in Dec 2025, raising $6.6M.